Top
ETAA1 has not been detected as a mutational cancer driver

ETAA1
Ensembl id ENSG00000143971
Mutated samples
Coding Sequence 44 (0.6%)
Protein Affecting 37 (0.5%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all ETAA1 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 9 8 2.17
Lung adenocarcinoma No 5 4 1.02
Serous ovarian adenocarcinoma No 3 3 0.95
Prostate adenocarcinoma No 2 2 0.82
Bladder carcinoma No 2 2 2.04
Medulloblastoma No 2 2 0.95
Lung squamous cell carcinoma No 3 2 1.15
Small cell lung carcinoma No 2 2 2.90
Colorectal adenocarcinoma No 2 2 0.87
Hepatocarcinoma No 1 1 1.11
Breast carcinoma No 2 1 0.09
Renal clear cell carcinoma No 1 1 0.24
Thyroid carcinoma No 1 1 0.31
Uterine corpus endometrioid carcinoma No 1 1 0.43
Chronic lymphocytic leukemia No 1 1 0.34
Multiple myeloma No 1 1 1.45
Lower grade glioma No 1 1 0.59
Head and neck squamous cell carcinoma No 1 1 0.27
Glioblastoma multiforme No 1 1 0.26
Non small cell lung carcinoma No 1 0 0.00
Stomach adenocarcinoma No 2 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence